Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III study.
Lee SA, Hong SJ, Sung JH, Kim KS, Kim SH, Cho JM, Chun SW, Lee SR, Kim CS, Kim TN, Kim DH, Park HC, Kim BJ, Kim HS, Choi JY, Hong YJ, Chung JW, Yoon SB, Lee SH, Lee CW. Lee SA, et al. Among authors: kim tn. Medicine (Baltimore). 2023 Nov 24;102(47):e36122. doi: 10.1097/MD.0000000000036122. Medicine (Baltimore). 2023. PMID: 38013289 Free PMC article. Clinical Trial.
Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study.
Kim KS, Han KA, Kim TN, Park CY, Park JH, Kim SY, Kim YH, Song KH, Kang ES, Kim CS, Koh G, Kang JG, Kim MK, Han JM, Kim NH, Mok JO, Lee JH, Lim S, Kim SS, Kim TH, Won KC, Lee KY, Cho JH, Han JY, Kim SH, Nah JJ, Song HR, Lee SE, Kim S; ENHANCE-D Investigators. Kim KS, et al. Among authors: kim yh, kim cs, kim ss, kim th, kim sh, kim sy, kim s, kim tn, kim nh, kim mk. Diabetes Metab. 2023 Jul;49(4):101440. doi: 10.1016/j.diabet.2023.101440. Epub 2023 Mar 9. Diabetes Metab. 2023. PMID: 36906135 Free article. Clinical Trial.
Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study.
Moon JS, Suh S, Kim SS, Jin HY, Kim JM, Jang MH, Lee KA, Lee JH, Chung SM, Lyu YS, Kim JH, Kim SY, Jang JE, Kim TN, Kim SW, Jeon E, Cho NH, Kim MK, Kim HS, Nam-Goong IS, Kim ES, Chung JO, Cho DH, Lee CW, Kim YI, Chung DJ, Won KC, Kim IJ, Park TS, Kim DK, Shon H. Moon JS, et al. Among authors: kim ss, kim yi, kim ij, kim jm, kim sw, kim sy, kim dk, kim tn, kim hs, kim jh, kim mk, kim es. Diabetes Metab J. 2021 Sep;45(5):675-683. doi: 10.4093/dmj.2020.0107. Epub 2020 Aug 12. Diabetes Metab J. 2021. PMID: 32794385 Free PMC article.
Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study.
Kim JM, Kim SS, Kim JH, Kim MK, Kim TN, Lee SH, Lee CW, Park JY, Kim ES, Lee KJ, Choi YS, Kim DK, Kim IJ. Kim JM, et al. Among authors: kim ss, kim ij, kim dk, kim tn, kim jh, kim mk, kim es. Diabetes Metab J. 2020 Feb;44(1):67-77. doi: 10.4093/dmj.2018.0274. Epub 2019 Jul 11. Diabetes Metab J. 2020. PMID: 31339011 Free PMC article. Clinical Trial.
High-sensitivity C-reactive protein in the low- and intermediate-Framingham risk score groups: analysis with 18F-fluorodeoxyglucose positron emission tomography.
Yang SJ, Kim S, Choi HY, Kim TN, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Yang SJ, et al. Among authors: kim sg, kim s, kim tn, kim nh. Int J Cardiol. 2013 Mar 10;163(3):277-281. doi: 10.1016/j.ijcard.2011.06.054. Epub 2011 Jun 29. Int J Cardiol. 2013. PMID: 21719129 Clinical Trial.
Hepatokines as a Molecular Transducer of Exercise.
Seo DY, Park SH, Marquez J, Kwak HB, Kim TN, Bae JH, Koh JH, Han J. Seo DY, et al. Among authors: kim tn. J Clin Med. 2021 Jan 20;10(3):385. doi: 10.3390/jcm10030385. J Clin Med. 2021. PMID: 33498410 Free PMC article. Review.
283 results